Human complement activation and anaphylatoxins generation induced by snake venom toxins from Bothrops genus

Molecular Immunology

Volumn 47, Issue 16, 2010, Pages 2537-2544

  Pidde Queiroz, Giselle ^a   Furtado, Maria de Fátima ^a   Filgueiras, Carlos F ^a   Pessoa, Lucas A ^a   Spadafora Ferreira, Mônica ^a   van den Berg, Carmen W ^b   Tambourgi, Denise V ^a  

^a INSTITUTO BUTANTAN   (Brazil)

^b CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Anaphylatoxins; Bothrops spp. venoms; C3; C4; Complement activation pathways; Complement regulatory proteins; Inhibitors; Proteases

Indexed keywords

ANAPHYLATOXIN; CD59 ANTIGEN; COMPLEMENT COMPONENT C1; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; COMPLEMENT COMPONENT C5A; COMPLEMENT INHIBITOR; LECTIN; METALLOPROTEINASE INHIBITOR; SERINE PROTEINASE INHIBITOR; SNAKE VENOM; TRANSCRIPTION FACTOR DAF 16;

ARTICLE; BRAZIL; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; CONTROLLED STUDY; ENZYMATIC DEGRADATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; HEMOLYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL;

ANAPHYLATOXINS; ANIMALS; BOTHROPS; COMPLEMENT ACTIVATION; HUMANS; METALLOPROTEASES; SERINE PROTEASES; VIPER VENOMS;

BOTHROPS; SERPENTES;

EID: 78649319275     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2010.07.003     Document Type: Article

References (32)

1. Alam J.M., Qasim R., Alam S.M. Enzymatic activities of some snake venoms from families Elapidae and Viperidae. Pak. J. Pharm. Sci. 1996, 9:37-41.
2. Beinrohr L., Dobó J., Závodszky P., Gál P. C1, MBL-MASPs and C1-inhibitor: novel approaches for targeting complement-mediated inflammation. Trends Mol. Med. 2006, 14:511-521.
3. Bowen B., Hawk J.J., Sibunka S., Hovick S., Weiler J.M. A review of the reported defects in the human C1 esterase inhibitor gene producing hereditary angioedema including four new mutations. Clin. Immunol. 2001, 98:157-163.
4. Braud S., Bon C., Wisner A. Snake venom proteins acting on hemostasis. Biochimie 2000, 82:851-859.
5. Carroll M.C. Complement and humoral immunity. Vaccine 2008, 26(Suppl. 8):I28-I33.
6. Chippaux J.P., Williams V., White J. Snake venom variability: methods of study, results and interpretation. Toxicon 1991, 29:1279-1303.
7. Danilova N. The evolution of immune mechanisms. J. Exp. Zool. B: Mol. Dev. Evol. 2006, 306:496-520.
8. Davis A.E. New treatments addressing the pathophysiology of hereditary angioedema. Clin. Mol. Allergy 2008, 6:2.
9. Fox J.W., Ma L., Nelson K., Sherman N.E., Serrano S.M. Comparison of indirect and direct approaches using ion-trap and Fourier transform ion cyclotron resonance mass spectrometry for exploring viperid venom proteomes. Toxicon 2006, 47:700-714.
10. Götze O., Müller-Eberhard H.J. The C3-activator system: an alternate pathway of complement-activation. J. Exp. Med. 1971, 3:90-108.
11. Gutiérrez J.M., Rucavado A. Snake venom metalloproteinase: their role in the pathogenesis of local tissue damage. Biochimie 2000, 82:841-850.
12. Hayashi M.A., Camargo A.C. The bradykinin-potentiating peptides from venom gland and brain of Bothrops jararaca contain highly site specific inhibitors of the somatic angiotensin-converting enzyme. Toxicon 2005, 4:1163-1170.
13. Jorge M.T., Ribeiro L.A., O'Connell J.L. Prognostic factors for amputation in the case of envenoming by snakes of the Bothrops genus (Viperidae). Ann. Trop. Med. Parasitol. 1999, 93:401-408.
14. Kini R.M. Anticoagulant proteins from snake venoms: structure, function and mechanism. Biochem. J. 2006, 397:377-387.
15. Kress L.F., Catanese J., Hirayama T. Analysis of the effects of snake venom proteinases on the activity of human plasma C1 esterase inhibitor, alpha 1-antichymotrypsin and alpha 2-antiplasmin. Biochim. Biophys. Acta 1983, 745:113-120.
16. Köhl J. Self, non-self, and danger: a complementary view. Adv. Exp. Med. Biol. 2006, 586:71-94.
17. 4. Nature 1970, 227:680-685.
18. Lu Q., Clemetson J.M., Clemetson K.J. Snake venoms and hemostasis. J. Thromb. Haemost. 2005, 3:1791-1799.
19. Marsh N., Williams V. Practical applications of snake venom toxins in haemostasis. Toxicon 2005, 45:1171-1181.
20. Müller-Eberhard H.J., Fjellstrom K.E. Isolation of the anti-complementary protein from cobra venom and its mode of action on C3. J. Immunol. 1971, 6:1666-1672.
21. Nielsen C.H., Fischer E.M., Leslie R.G. The role of complement in the acquired immune response. Immunology 2000, 100:4-12.
22. Otero R., Gutiérrez J., Beatriz Mesa M., Duque E., Rodríguez O., Luis Arango J., Gómez F., Toro A., Cano F., María Rodríguez L., Caro E., Martínez J., Cornejo W., Mariano Gómez L., Luis Uribe F., Cárdenas S., Núñez V., Díaz A. Complications of Bothrops, Porthidium, and Bothriechis snakebites in Colombia. A clinical and epidemiological study of 39 cases attended in a university hospital. Toxicon 2002, 40:1107-1114.
23. Pangburn M.K., Ferreira V.P., Cortes C. Discrimination between host and pathogens by the complement system. Vaccine 2008, 26:115-121.
24. Queiroz G.P., Pessoa L.A., Portaro F.C., Furtado M., de F., Tambourgi D.V. Interspecific variation in venom composition and toxicity of Brazilian snakes from Bothrops genus. Toxicon 2008, 52:842-851.
25. Ribeiro L.A., Jorge M.T. Acidentes por serpentes do gênero Bothrops: série de 3139 casos. Rev. Soc. Bras. Med. Trop. 1997, 30:475-480.
26. Rosenfeld G. Symptomatology, pathology and treatment of snake bites in South America. Venomous Animals and Their Venoms 1971, 345-403. Academic Press, New York. W. Bucherl, E.E. Buckley (Eds.).
27. Sjöberg A.P., Trouw L.A., Blom A.M. Complement activation and inhibition: a delicate balance. Trends Immunol. 2009, 30:83-90.
28. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications, 1979. Biotechnology 1992, 24:145-149.
29. Unsworth D.J. Complement deficiency and disease. J. Clin. Pathol. 2008, 61(9):1013-1017.
30. van den Berg C.W., Aerts P.C., Van Dijk H. In vivo anti-complementary activities of the cobra venom factors from Naja naja and Naja haje. J. Immunol. Methods 1991, 136:287-294.
31. Vogel C.W., Muller-Eberhard H.J. The cobra venom factor-dependent C3 convertase of human complement. A kinetic and thermodynamic analysis of a protease acting on its natural high molecular weight substrate. J. Biol. Chem. 1982, 14:8292-8299.
32. White J. Snake venoms and coagulopathy. Toxicon 2005, 45:951-967.